Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 9 studies | 19% ± 7% | |
| memory B cell | 8 studies | 20% ± 4% | |
| plasmacytoid dendritic cell | 7 studies | 22% ± 7% | |
| fibroblast | 6 studies | 26% ± 9% | |
| ciliated cell | 6 studies | 38% ± 9% | |
| pericyte | 5 studies | 20% ± 5% | |
| natural killer cell | 5 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| classical monocyte | 4 studies | 25% ± 8% | |
| epithelial cell | 4 studies | 38% ± 14% | |
| naive B cell | 3 studies | 19% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| conventional dendritic cell | 3 studies | 32% ± 7% | |
| non-classical monocyte | 3 studies | 32% ± 7% | |
| gamma-delta T cell | 3 studies | 28% ± 11% | |
| connective tissue cell | 3 studies | 24% ± 7% | |
| plasma cell | 3 studies | 25% ± 11% | |
| endothelial cell | 3 studies | 27% ± 9% | |
| abnormal cell | 3 studies | 21% ± 7% | |
| regulatory T cell | 3 studies | 18% ± 2% | |
| basal cell | 3 studies | 33% ± 10% | |
| erythrocyte | 3 studies | 32% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2548.53 | 258 / 258 | 100% | 41.46 | 230 / 230 |
| esophagus | 100% | 1969.48 | 1445 / 1445 | 100% | 20.48 | 183 / 183 |
| liver | 100% | 1756.32 | 226 / 226 | 100% | 27.66 | 406 / 406 |
| ovary | 100% | 2383.66 | 180 / 180 | 100% | 46.53 | 430 / 430 |
| skin | 100% | 2093.72 | 1809 / 1809 | 100% | 50.44 | 472 / 472 |
| thymus | 100% | 2143.41 | 653 / 653 | 100% | 47.97 | 605 / 605 |
| uterus | 100% | 2924.21 | 170 / 170 | 100% | 49.09 | 459 / 459 |
| brain | 100% | 2301.21 | 2638 / 2642 | 100% | 48.21 | 705 / 705 |
| kidney | 100% | 2045.16 | 89 / 89 | 100% | 30.70 | 898 / 901 |
| prostate | 100% | 2825.37 | 245 / 245 | 100% | 50.25 | 500 / 502 |
| pancreas | 100% | 1829.79 | 328 / 328 | 99% | 36.55 | 177 / 178 |
| intestine | 100% | 2138.09 | 966 / 966 | 99% | 33.88 | 524 / 527 |
| stomach | 100% | 2116.02 | 359 / 359 | 99% | 28.64 | 284 / 286 |
| breast | 100% | 1779.38 | 459 / 459 | 99% | 41.87 | 1109 / 1118 |
| lung | 100% | 1789.60 | 576 / 578 | 99% | 32.86 | 1146 / 1155 |
| bladder | 100% | 2239.14 | 21 / 21 | 99% | 40.58 | 498 / 504 |
| adipose | 100% | 1654.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 45.95 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 54.36 | 29 / 29 |
| peripheral blood | 100% | 2160.96 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2297.74 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 41.31 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 30.73 | 1 / 1 |
| blood vessel | 100% | 1707.60 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 1409.60 | 857 / 861 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1379.23 | 799 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
| GO_0008023 | Cellular component | transcription elongation factor complex |
| GO_0000993 | Molecular function | RNA polymerase II complex binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ELOF1 |
| Protein name | Transcription elongation factor 1 homolog |
| Synonyms | hCG_29982 |
| Description | FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . FUNCTION: Transcription elongation factor implicated in the maintenance of proper chromatin structure in actively transcribed regions. . |
| Accessions | ENST00000586683.5 K7EMV4 K7EPC8 ENST00000587806.5 ENST00000591912.1 K7EN05 ENST00000591674.5 ENST00000586120.5 ENST00000590700.5 ENST00000589171.5 A0A024R7E8 ENST00000252445.8 P60002 K7EQ44 |